Difference between Oral Isosorbide Mononitrate & Sildenafil Citrate Therapy in Reducing Umbilical Artery Doppler Indices in Pregnancies with IUGR;

Paula Refaat Rashed Naseef;

Abstract


SUMMARY
ntrauterine growth restriction (IUGR) is an important cause of perinatal morbidity and mortality. The accurate assessment of fetal growth during pregnancy is difficult, but recent advances have improved this important aspect of obstetric care with positive implications for antenatal patients and their babies.
The term IUGR defines an infant that has failed to achieve a weight threshold (usually defined as the 10th percentile). Normal fetal growth is dependent on intrinsic (genetic) and extrinsic (placental and maternal) factors. A failure of any or a combination of these factors will impair growth in affected fetuses. The identification of the specific cause of IUGR prior to delivery is essential because clinical management, parental counselling and pregnancy outcome are linked to the etiology.
To achieve optimal fetal growth, adequate blood flow in utero-placental vascular unit is essential. Abnormal vasculature adaptation, result


Other data

Title Difference between Oral Isosorbide Mononitrate & Sildenafil Citrate Therapy in Reducing Umbilical Artery Doppler Indices in Pregnancies with IUGR;
Other Titles الفرق بين العلاج الفموى بأحادي نترات إيزوسوربيد وسترات السيلدنافيل في حالات الحمل التي تتسم بتأخر نمو الجنين داخل الرحم تجربة عشوائية معتمدة على مجموعة ضابطة
Authors Paula Refaat Rashed Naseef
Issue Date 2017

Attached Files

File SizeFormat
J5033.pdf330.34 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 11 in Shams Scholar
downloads 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.